Today, a Director at Inogen (INGN), Raymond Huggenberger, bought shares of INGN for $110.5K.
Following Raymond Huggenberger’s last INGN Buy transaction on November 04, 2014, the stock climbed by 101.3%. This recent transaction increases Raymond Huggenberger’s holding in the company by 22.13% to a total of $982.7K.
See today’s analyst top recommended stocks >>
Based on Inogen’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $95.29 million and quarterly net profit of $16.43 million. In comparison, last year the company earned revenue of $69.03 million and had a net profit of $7.34 million. INGN’s market cap is $2.71B and the company has a P/E ratio of 69.05. Currently, Inogen has an average volume of 121.8K.
Based on 3 analyst ratings, the analyst consensus is Strong Buy with an average price target of $260.33, reflecting a 104.7% upside. Starting in February 2018, INGN received 23 Buy ratings in a row. One of the top 25 analysts, according to TipRanks.com, recently recommended Buy INGN with a $290 price target.
The insider sentiment on Inogen has been positive according to 90 insider trades in the past three months. This sentiment is higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
